Prescription drug abuse lecture at CDA Presents

A lecture will be held at CDA Presents The Art and Science of Dentistry in San Francisco to help dentists navigate the professional responsibilities and regulatory requirements of pain management and opioid diversion.

Led by Michael Bundy, PharmD, DMD, MD, and Tony Parks, PharmD, JD, the lecture titled "Pain Management and Opioid Reduction in Dentistry" will describe how to develop a plan for acute pain control for patients that effectively manages dental pain while at the same time prevents the overprescribing of narcotic pain medication. The course will also explain the use of CURES and help dentists to recognize substance abuse behaviors.

Dentists can expect to leave the lecture with a better understanding of what a safe and effective regimen for acute pain control for the dental patient looks like; what the reasonable and effective alternatives to excessive narcotic pain medication usage are; and the important role dentists play in substance abuse detection and diversion.

The lecture will be held from 12:30 to 3:30 p.m. on Saturday, Sept. 10. For more information, see page 69 of the CDA Presents Program. Learn more about the San Francisco convention at cdapresents.com/SF2016.

CURES registration

Dentists who still need to register for CURES can visit oag.ca.gov/cures. Dentists seeking help with CURES can access training videos, publications and FAQ.

Additionally, the Department of Justice offers the following information to clarify the enrollment process:

  • If already enrolled in CURES 1.0, a provider's registration carries over to CURES 2.0. Reregistration in CURES 2.0 is unnecessary if a provider was approved in the CURES 1.0 system.
  • CURES users' internet browsers must be compliant with the system's security requirements. This level of security is available on Microsoft Internet Explorer Version 11.0 or greater, Mozilla FireFox, Google Chrome or Safari. DOJ has not provided an exact date for how long CURES 1.0 will be available, and recommends users and prospective users update their web browsers to compliant web browsers as soon as possible.

CDA recently hosted a webinar to help guide members through the CURES registration process. To view the webinar, visit cda.org/cures.

For more information on the current science and practice of pain management in dentistry, see the November 2015 Journal of the California Dental Association.

Related Items

A check of the state’s prescription drug monitoring program may become mandatory under a proposed bill requiring prescribers, including dentists with U.S. Drug Enforcement Administration registrations, to check the Controlled Substance Utilization Review and Evaluation System when writing a prescription for Schedule II-IV medications.

In collaboration with pharmacy colleagues, authors of the November issue of the Journal of the California Dental Association present the most current information on pain management in dentistry. This issue includes timely information relative to opioid medication regulations and abuse.

In California, more than 1 billion dosage units of hydrocodone combination products were dispensed in the 2013-14 fiscal year, according to the state’s Controlled Substance Utilization Review and Evaluation System (CURES). What's more, approximately 100 percent of the hydrocodone use worldwide occurs in the U.S., according to Tony J. Park, PharmD, JD, who co-hosted a lecture on the topic at CDA Presents The Art and Science of Dentistry in Anaheim on May 2.